Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions.
about
Choline transporter-like protein 4 (CTL4) links to non-neuronal acetylcholine synthesisMetabolic Imaging to Assess Treatment Response to Cytotoxic and Cytostatic AgentsPSMA Ligands for Radionuclide Imaging and Therapy of Prostate Cancer: Clinical StatusCancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapiesCirculating Phospholipids as Biomarkers of Breast Cancer: A ReviewMagnetic resonance spectroscopy detectable metabolomic fingerprint of response to antineoplastic treatmentBiomarkers in preclinical cancer imaging.Functional interactions between Choline kinase α, epidermal growth factor receptor and c-Src in breast cancer cell proliferationInhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells.Imaging and 'omic' methods for the molecular diagnosis of cancer.Activation of a PARACEST agent for MRI through selective outersphere interactions with phosphate diestersActivation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.Functional and molecular imaging with MRI: potential applications in paediatric radiology.Lipidomic analysis of skeletal muscle tissues of p53 knockout mice by nUPLC-ESI-MS/MS.PSMA-targeted theranostic nanoplex for prostate cancer therapy.Breast Tissue Metabolism by Magnetic Resonance Spectroscopy.18F-FDG PET/CT for image-guided and intensity-modulated radiotherapy.Monitoring the Effect of Docetaxel Treatment in MCF7 Xenografts Using Multimodal In Vivo and Ex Vivo Magnetic Resonance Methods, Histopathology, and Gene ExpressionAnalysis of cancer cell lipids using matrix-assisted laser desorption/ionization 15-T Fourier transform ion cyclotron resonance mass spectrometry.Association of lipid metabolism with ovarian cancerDelineating metabolic signatures of head and neck squamous cell carcinoma: phospholipase A2, a potential therapeutic target.Nanoplex delivery of siRNA and prodrug enzyme for multimodality image-guided molecular pathway targeted cancer therapyAnalysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research.Assessment of tracer 99mTc(V)-DMSA uptake as a measure of tumor cell proliferation in vitro.Clinical characteristics and biomarkers of breast cancer associated with choline concentration measured by 1H MRS.Serial magnetic resonance spectroscopy reveals a direct metabolic effect of cediranib in glioblastoma.Choline kinase overexpression increases invasiveness and drug resistance of human breast cancer cellsHigh-field small animal magnetic resonance oncology studies.Prognosis Related to Metastatic Burden Measured by ¹⁸F-Fluorocholine PET/CT in Castration-Resistant Prostate Cancer.Egg, red meat, and poultry intake and risk of lethal prostate cancer in the prostate-specific antigen-era: incidence and survival.A proton nuclear magnetic resonance-based metabonomics study of metabolic profiling in immunoglobulin a nephropathy.EDI3 links choline metabolism to integrin expression, cell adhesion and spreadingTargeted molecular imaging in oncology: focus on radiation therapy.Muscarinic receptor agonists and antagonists: effects on cancerCholine: Dietary Requirements and Role in Brain DevelopmentApplication of metabonomics in drug development.Metabolomics in biomarker discovery: future uses for cancer prevention.Cholinergic Targets in Lung CancerThe role of metabolic imaging in radiation therapy of prostate cancer.NMR metabonomics for mammalian cell metabolism studies.
P2860
Q24339568-522BBA63-3D57-449D-8C28-25D1DC9BFD28Q26740567-00158788-B804-4D5B-B73E-5861F0C5F013Q26774920-A932DA71-5A16-4EE9-B719-3330B9E9064DQ26823118-C1432B92-EC39-4CCA-9352-C4044C2A2D6DQ28075134-91B8BF5D-569D-464D-A7E2-DC44258E46B3Q28477468-88A6B849-488B-42B2-8FA4-8F9E3C9474DDQ30416864-21EAB8BD-DBEC-4A9E-B3D8-B3CF49396FC2Q30424954-37046701-D9D3-4F6F-BEC1-1CA3C3336DD3Q33576337-27BD07C7-41B7-4B76-B79A-8F26D833FB0AQ33577268-DCFBF5E0-F46F-4237-B45C-6F6EF5A5E7C5Q33590028-2D933049-57F9-4926-A0A4-340DF1DA0B5EQ33699139-71C97F23-662F-4F8E-9C3D-EAA0E6C4BB3EQ33726910-EC32DAF3-E8EC-4525-82AE-53EE2347772EQ33789472-FE8BBBA5-158A-48CD-BC90-7C333022F632Q33791366-7649E1A8-049B-4380-A2CC-1A4ABD00D4A2Q33844954-527AFB5E-20D9-4E45-BEDB-05DDBC3CC05CQ33973367-5C56B7A9-67C6-4052-BF07-B040AFAEE0C1Q34041364-F0075A74-7600-4AD2-B260-F8120D69B3E9Q34157026-42D5A603-30EC-47D9-8CAA-8E0D83FFF327Q34171997-90C332F3-A772-4288-B7E5-39BB85990488Q34320362-7A5B7FF4-2EAD-4E46-B6FE-3448D796D456Q34348175-4733FF17-6562-4F0A-84B2-7805BFB6DEADQ34551523-A33DC12C-DB51-4C68-B1AA-AF7EF9DF556BQ34555868-4C47722E-7B0B-4D47-B30F-59A185866B02Q34788629-9099C0C4-EBE9-46D2-AC60-074CCC8F0C47Q35022254-D1F7B96A-6F17-4C4C-A21A-AB186E6D669FQ35046962-054FF38A-2DCE-42C0-BD6C-B9A3FA885A5CQ35312455-8C42A993-2116-4B81-A5C8-65260A3E60B9Q35582133-636CF811-6480-4308-BD5A-DD9821D0EAA9Q35597054-61F1A622-2D72-46A0-988B-C4DF3B31C4D3Q35864994-BE05BC51-D4C6-4D30-A33B-273B9D0C55CDQ36124959-12C4093B-ED9B-4B31-AB60-139EBAFE1618Q36528175-6792207F-7247-4DAA-9A80-EE560B6CA8D9Q36706667-A8999FAA-8439-4097-8B1D-BF28400455F0Q36842222-16B1FBE1-F5DC-4DD5-BCF8-7B84FD894743Q37074082-6070BA12-3A42-44EA-8E5F-B5433168E450Q37074142-0428B80A-B4AD-49A0-BC5F-213945ED7BC8Q37127226-FDCA911F-099F-4E36-9F63-CC83C63281B4Q37395733-10ADBD70-FB85-41F2-B908-9EAFCC5F51E4Q37810162-187D6FCF-BC05-4996-AB31-256D6F7110E5
P2860
Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Choline phospholipid metabolis ...... pharmaceutical interventions.
@ast
Choline phospholipid metabolis ...... pharmaceutical interventions.
@en
type
label
Choline phospholipid metabolis ...... pharmaceutical interventions.
@ast
Choline phospholipid metabolis ...... pharmaceutical interventions.
@en
prefLabel
Choline phospholipid metabolis ...... pharmaceutical interventions.
@ast
Choline phospholipid metabolis ...... pharmaceutical interventions.
@en
P2093
P356
P1476
Choline phospholipid metabolis ...... r pharmaceutical interventions
@en
P2093
Kristine Glunde
Noriko Mori
Zaver M Bhujwalla
P304
P356
10.1021/MP060067E
P407
P577
2006-09-01T00:00:00Z